Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 23, 2020

View Archived Issues

Equine encephalitis' entry elucidated

Initiation of RHB-204 phase III trial as first-line treatment of nontuberculous mycobacteria disease

SPL-7013 demonstrates potent antiviral activity against human RSV

MD Anderson and Obsidian collaborate to advance novel cytoTIL therapy for solid tumors

EicOsis completes phase Ia single-ascending dose trial of EC-5026

Immunity stays strong in longest-term COVID study to date

Slowing cholera down protects survivors of infection

Abbisko Therapeutics patents ROR-gammaT agonists

Beijing Jialin Pharmaceutical discloses new SMARCA2-targeting compounds

AiCuris presents new HBV inhibitors

Genfleet Therapeutics synthesizes KRAS inhibitors

Initial phase I data presented for BMS-986253 plus nivolumab in advanced cancer

Early first-in-human data reported for AMG-404

GSK presents phase II data for linerixibat, a potential oral treatment for primary biliary cirrhosis

RAP-011: a sotatercept analogue active in in vivo models of PAH

First cohort dosed in Molecular Partners' phase I study of COVID-19 candidate MP-0420

Tebentafusp improves OS in phase III trial in metastatic uveal melanoma

Bio-Path studies BP-1002 in refractory or relapsed lymphoma and CLL

FDA issues EUA for Regeneron's casirivimab and imdevimab for mild to moderate COVID-19

Neglected tropical ecosystems: Coral reef denizen's microbiome yields candidate Candida fighters

Phase II dosing begins with brequinar to treat COVID-19

Pooled analysis shows AZD-1222 effective at preventing COVID-19

European Commission approves quadrivalent meningococcal conjugate vaccine MenQuadfi

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...